Upregulation of endogenous ICAM-1 reduces ovarian cancer cell growth in the absence of immune cells

Autor: de Groote, Marloes L., Kazemier, Hinke G., Huisman, Christian, van der Gun, Bernardina T. F., Faas, Marijke M., Rots, Marianne G.

Publikováno v: International Journal of Cancer, 134(2), 280-290. Wiley

Ovarian cancer is a difficult-to-treat cancer with a 5-year survival rate of only approximate to 45%, due to late diagnosis and therapy resistance. In need of new therapeutic approaches, induction of intercellular adhesion molecule (ICAM)-1 expressio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::b1a58b26a50ccc0f9cd66a29f6ed4a81
https://research.rug.nl/en/publications/1cc8eee3-f243-4236-8643-54db460088e5

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Upregulation of endogenous ICAM-1 reduces ovarian cancer cell growth in the absence of immune cells.

Autor: de Groote ML; Epigenetic Editing, Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Kazemier HG, Huisman C, van der Gun BT, Faas MM, Rots MG

Publikováno v: International journal of cancer [Int J Cancer] 2014 Jan 15; Vol. 134 (2), pp. 280-90. Date of Electronic Publication: 2013 Aug 10.